)
Rong Xin
CEO
RecoRNA Biotech
Ms. Rong Xin, MD, graduated from the Shanghai Jiao Tong University School of Clinical Medicine and currently serves as Deputy Director of the MAH (Marketing Authorization Holder) Technology Transfer Group of the Chinese Pharmaceutical Association, Deputy Director of the Pharmaceutical Engineering Committee of the Guangdong Pharmaceutical Association, and Deputy Secretary General of the Zhongshan Pharmaceutical Industry Association. She previously held roles at GSK and AstraZeneca, bringing extensive experience in R&D, operation management, regulatory strategy, and product lifecycle management. Dr. Rong has overseen more than 50 drug product registrations, including commercial launches in the United States and Europe, and has led multiple EU and FDA submissions. She has also advanced several innovative medicines from clinical development through to commercial launch.
Sessions
-
24-Jun-2026Theater 1RecoRNA (Hong Kong) Biotechnology Co., Ltd.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}